Who
Julie O'Neill
Director
Company insider
Files Form 4 as: Director, Icon; Director, HOOKIPA Pharma; EVP. Global Operations, Alexion Pharmaceuticals.
In numbers
- Trades disclosed
- 60
- Buys
- 0
- Sells
- 21
- Bought
- $0
- Sold
- $6.3M
- Companies
- 3
- Companies where not an officer
- 2
- First trade
- 5 Feb 2015
- Last trade
- 11 Aug 2026
- Last filed
- 12 Aug 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 11 Aug 2026filed 12 Aug 2026 | ICLR IconLife-science tools | SEC FORM 4 Sold | $15K95 at $162.72 | filing |
| 11 Aug 2026filed 12 Aug 2026 | ICLR IconLife-science tools | SEC FORM 4 Sold | $17K105 at $163.77 | filing |
| 11 Aug 2026filed 12 Aug 2026 | ICLR IconLife-science tools | SEC FORM 4 Sold | $106K642 at $164.47 | filing |
| 11 Aug 2026filed 12 Aug 2026 | ICLR IconLife-science tools | SEC FORM 4 Sold | $12K73 at $165.51 | filing |
| 11 Aug 2026filed 12 Aug 2026 | ICLR IconLife-science tools | SEC FORM 4 Sold | $15K95 at $162.72 | filing |
| 11 Aug 2026filed 12 Aug 2026 | ICLR IconLife-science tools | SEC FORM 4 Sold | $17K105 at $163.77 | filing |
| 11 Aug 2026filed 12 Aug 2026 | ICLR IconLife-science tools | SEC FORM 4 Sold | $106K642 at $164.47 | filing |
| 11 Aug 2026filed 12 Aug 2026 | ICLR IconLife-science tools | SEC FORM 4 Sold | $12K73 at $165.51 | filing |
| 10 Aug 2026filed 12 Aug 2026 | ICLR IconLife-science tools | SEC FORM 4 Code M | —1,732 | filing |
| 10 Aug 2026filed 12 Aug 2026 | ICLR Iconoption or derivative · Life-science tools | SEC FORM 4 Code M | —1,732 at $0.00 | filing |
| 10 Aug 2026filed 12 Aug 2026 | ICLR Iconoption or derivative · Life-science tools | SEC FORM 4 Code A | —1,324 at $0.00 | filing |
| 10 Aug 2026filed 12 Aug 2026 | ICLR Iconoption or derivative · Life-science tools | SEC FORM 4 Code M | —1,732 at $0.00 | filing |
| 10 Aug 2026filed 12 Aug 2026 | ICLR Iconoption or derivative · Life-science tools | SEC FORM 4 Code A | —1,324 at $0.00 | filing |
| 10 Aug 2026filed 12 Aug 2026 | ICLR IconLife-science tools | SEC FORM 4 Code M | —1,732 | filing |
| 17 Jun 2024filed 18 Jun 2024 | HOOKIPA Pharmaoption or derivative | SEC FORM 4 Code A | —49,000 at $0.00 | filing |
| 9 Jun 2023filed 9 Jun 2023 | HOOKIPA Pharmaoption or derivative | SEC FORM 4 Code A | —26,000 at $0.00 | filing |
| 30 Jun 2022filed 1 Jul 2022 | HOOKIPA Pharmaoption or derivative | SEC FORM 4 Code A | —20,000 at $0.00 | filing |
| 1 Jun 2021filed 4 Jun 2021 | HOOKIPA Pharmaoption or derivative | SEC FORM 4 Code A | —9,600 at $0.00 | filing |
| 21 Oct 2020filed 23 Oct 2020 | HOOKIPA Pharma | SEC FORM 4 Code A | —4,969 at $0.00 | filing |
| 18 Jun 2020filed 19 Jun 2020 | HOOKIPA Pharmaoption or derivative | SEC FORM 4 Code A | —9,600 at $0.00 | filing |
News
Head to Head Review: CryoPort (NASDAQ:CYRX) and Icon (NASDAQ:ICLR)ICLR · themarketsdaily.com · 20 Oct 2026
0 headlines in the last 90 days name Julie O'Neill; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.